| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Outlook Therapeutics, Inc. (OTLK) | P | 2,525,252 | $0.00 | $0.00 | View Details Filing |
| Aug 12, 2026 | Outlook Therapeutics, Inc. (OTLK) | P | 2,525,252 | $0.99 | $2,499,999.48 | View Details Filing |
| May 28, 2026 | Outlook Therapeutics, Inc. (OTLK) | P | 3,458,571 | - | - | View Details Filing |
| May 28, 2026 | Outlook Therapeutics, Inc. (OTLK) | H | 3,458,571 | - | - | View Details Filing |
| May 28, 2026 | Outlook Therapeutics, Inc. (OTLK) | P | 8,539,709 | $0.59 | $4,999,999.62 | View Details Filing |
| May 28, 2026 | Outlook Therapeutics, Inc. (OTLK) | H | 8,571,428 | - | - | View Details Filing |
| May 28, 2026 | Outlook Therapeutics, Inc. (OTLK) | P | 8,571,428 | - | - | View Details Filing |
| May 28, 2026 | Outlook Therapeutics, Inc. (OTLK) | P | 3,458,571 | - | - | View Details Filing |
| May 28, 2026 | Outlook Therapeutics, Inc. (OTLK) | H | 3,458,571 | - | - | View Details Filing |